Citations

Showing 10 of 108060 citations.

Monosialoganglioside‐Containing Nanoliposomes Restore Endothelial Function Impaired by AL Amyloidosis Light Chain Proteins
Truran, Seth , Weissig, Volkmar , Guzman‐Villanueva, Diana, Karamanova, Nina , Senapati, Subhadip , Burciu, Camelia , Ramı́rez-Alvarado, Marina , Blancas‐Mejía, Luis M. , Lindsay, Stuart , Hari, Parameswaran , Migrino, Raymond Q. , Ramirez-Alvarado, Marina, Blancas-Mejia, Luis M, Franco, Daniel , Ramirez-Alvarado, Marina , Hari, Parameswaran

Mayo Clinic

Journal of the American Heart Association | June 14, 2016 | Volume: 5 | Issue: 6 | Pages: No page available

10.1161/jaha.116.003318 | PMID 27412900 Get It

Background Light chain amyloidosis (AL) is associated with high mortality, especially in patients with advanced cardiovascular involvement. It is caused by toxicity of misfolded light chain proteins ( LC ) in vascular, cardiac, and other tissues. There is no treatment to reverse LC tissue toxicity. We tested the hypothesis that nanoliposomes composed of monosialoganglioside, phosphatidylcholine, and cholesterol (GM1 ganglioside–containing nanoliposomes [ NLGM 1]) can protect against LC ‐induced human microvascular dysfunction and assess mechanisms behind the protective effect. Methods and Results The dilator responses of ex vivo abdominal adipose arterioles from human participants without AL to acetylcholine and papaverine were measured before and after exposure to LC (20 μg/mL) with or without NLGM 1 (1:10 ratio for LC : NLGM 1 mass). Human umbilical vein endothelial cells were exposed for 18 to 20 hours to vehicle, LC with or without NLGM 1, or NLGM 1 and compared for oxidative and nitrative stress response and cellular viability. LC impaired arteriole dilator response to acetylcholine, which was restored by co‐treatment with NLGM 1. LC decreased endothelial cell nitric oxide production and cell viability while increasing superoxide and peroxynitrite; these adverse effects were reversed by NLGM 1. NLGM 1 increased endothelial cell protein expression of antioxidant enzymes heme oxygenase 1 and NAD (P)H quinone dehydrogenase 1 and increased nuclear factor, erythroid 2 like 2 (Nrf‐2) protein. Nrf‐2 gene knockdown reduced antioxidant stress response and reversed the protective effects of NLGM 1. Conclusions NLGM1 protects against LC ‐induced human microvascular endothelial dysfunction through increased nitric oxide bioavailability and reduced oxidative and nitrative stress mediated by Nrf‐2–dependent antioxidant stress response. These findings point to a potential novel therapeutic approach for light chain amyloidosis.
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
Boddicker, Rebecca L., Razidlo, Gina L. , Dasari, Surendra , Zeng, Yu , Hu, Guangzhen , Knudson, Ryan A., Greipp, Patricia T. , Davila, Jaime , Johnson, Sarah H. , Porcher, Julie C., Smadbeck, James B. , Eckloff, Bruce W., Billadeau, Daniel D. , Kurtin, Paul J. , McNiven, Mark A. , Link, Brian K. , Ansell, Stephen M. , Asmann, Yan W. , Vasmatzis, George , Feldman, Andrew L. , Luchtel, Rebecca A. , Davila, Jaime I, Cerhan, James R. , Feldman, Andrew L , Link, Brian K , Razidlo, Gina L , Greipp, Patricia T , Davila, Jaime I

Mayo Clinic

Blood | June 14, 2016 | Volume: 128 | Issue: 9 | Pages: 1234-1245

10.1182/blood-2016-03-707141 | PMID 27297792 Get It

Abstract Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of T-cell malignancies that generally demonstrate aggressive clinical behavior, often are refractory to standard therapy, and remain significantly understudied. The most common World Health Organization subtype is PTCL, not otherwise specified (NOS), essentially a “wastebasket” category because of inadequate understanding to assign cases to a more specific diagnostic entity. Identification of novel fusion genes has contributed significantly to improving the classification, biologic understanding, and therapeutic targeting of PTCLs. Here, we integrated mate-pair DNA and RNA next-generation sequencing to identify chromosomal rearrangements encoding expressed fusion transcripts in PTCL, NOS. Two of 11 cases had novel fusions involving VAV1, encoding a truncated form of the VAV1 guanine nucleotide exchange factor important in T-cell receptor signaling. Fluorescence in situ hybridization studies identified VAV1 rearrangements in 10 of 148 PTCLs (7%). These were observed exclusively in PTCL, NOS (11%) and anaplastic large cell lymphoma (11%). In vitro, ectopic expression of a VAV1 fusion promoted cell growth and migration in a RAC1-dependent manner. This growth was inhibited by azathioprine, a clinically available RAC1 inhibitor. We also identified novel kinase gene fusions, ITK-FER and IKZF2-ERBB4, as candidate therapeutic targets that show similarities to known recurrent oncogenic ITK-SYK fusions and ERBB4 transcript variants in PTCLs, respectively. Additional novel and potentially clinically relevant fusions also were discovered. Together, these findings identify VAV1 fusions as recurrent and targetable events in PTCLs and highlight the potential for clinical sequencing to guide individualized therapy approaches for this group of aggressive malignancies.
Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CII
Nasr, Samih H. , Dasari, Surendra , Hasadsri, Linda , Theis, Jason D. , Vrana, Julie A., Muppa, Prasuna, Zimmermann, Michael T. , Grogg, Karen L., Sethi, Sanjeev , Highsmith, W. Edward, Merlini, Giampaolo , Kurtin, Paul J. , Gertz, Morie A. , Dispenzieri, Angela , Leung, Nelson , Merlini, Giampaolo , Zimmermann, Michael T

Mayo Clinic

Journal of the American Society of Nephrology | June 13, 2016 | Volume: 28 | Issue: 2 | Pages: 439-445

10.1681/asn.2015111228 | PMID 27297947 Get It

Amyloidosis is characterized by extracellular deposition of misfolded proteins as insoluble fibrils. Most renal amyloidosis cases are Ig light chain, AA, or leukocyte chemotactic factor 2 amyloidosis, but rare hereditary forms can also involve the kidneys. Here, we describe the case of a 61-year-old woman who presented with nephrotic syndrome and renal impairment. Examination of the renal biopsy specimen revealed amyloidosis with predominant involvement of glomeruli and medullary interstitium. Proteomic analysis of Congo red–positive deposits detected large amounts of the Apo-CII protein. DNA sequencing of the APOC2 gene in the patient and one of her children detected a heterozygous c.206A→T transition, causing an E69V missense mutation. We also detected the mutant peptide in the proband’s renal amyloid deposits. Using proteomics, we identified seven additional elderly patients with Apo-CII–rich amyloid deposits, all of whom had kidney involvement and histologically exhibited nodular glomerular involvement. Although prior in vitro studies have shown that Apo-CII can form amyloid fibrils and that certain mutations in this protein promote amyloid fibrillogenesis, there are no reports of this type of amyloidosis in humans. We propose that this study reveals a new form of hereditary amyloidosis (AApoCII) that is derived from the Apo-CII protein and appears to manifest in the elderly and preferentially affect the kidneys.
Low–Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation
Zhang, Xin , Krier, James D., Carrascal, Carolina Amador, Greenleaf, James F. , Hedayat, Ahmad F. , Textor, Stephen C., Lerman, Lilach O. , Carrascal, Carolina Amador, Ebrahimi, Behzad , Lerman, Amir

Mayo Clinic

Journal of the American Society of Nephrology | June 13, 2016 | Volume: 27 | Issue: 12 | Pages: 3715-3724

10.1681/asn.2015060704 | PMID 27297945 Get It

Microvascular rarefaction distal to renal artery stenosis is linked to renal dysfunction and poor outcomes. Low–energy shockwave therapy stimulates angiogenesis, but the effect on the kidney microvasculature is unknown. We hypothesized that low–energy shockwave therapy would restore the microcirculation and alleviate renal dysfunction in renovascular disease. Normal pigs and pigs subjected to 3 weeks of renal artery stenosis were treated with six sessions of low–energy shockwave (biweekly for 3 consecutive weeks) or left untreated. We assessed BP, urinary protein, stenotic renal blood flow, GFR, microvascular structure, and oxygenation in vivo 4 weeks after completion of treatment, and then, we assessed expression of angiogenic factors and mechanotransducers (focal adhesion kinase and β 1-integrin) ex vivo . A 3-week low–energy shockwave regimen attenuated renovascular hypertension, normalized stenotic kidney microvascular density and oxygenation, stabilized function, and alleviated fibrosis in pigs subjected to renal artery stenosis. These effects associated with elevated renal expression of angiogenic factors and mechanotransducers, particularly in proximal tubular cells. In additional pigs with prolonged (6 weeks) renal artery stenosis, shockwave therapy also decreased BP and improved GFR, microvascular density, and oxygenation in the stenotic kidney. This shockwave regimen did not cause detectable kidney injury in normal pigs. In conclusion, low–energy shockwave therapy improves stenotic kidney function, likely in part by mechanotransduction-mediated expression of angiogenic factors in proximal tubular cells, and it may ameliorate renovascular hypertension. Low–energy shockwave therapy may serve as a novel noninvasive intervention in the management of renovascular disease.
Purple hands in multiple system atrophy
Fealey, Robert D., Benarroch, Eduardo E. , Sandroni, Paola , Low, Phillip A. , Coon, Elizabeth A. , Singer, Wolfgang

Mayo Clinic

Neurology | June 13, 2016 | Volume: 86 | Issue: 24 | Pages: 2314-2314

10.1212/wnl.0000000000002778 | PMID 27298449 Get It

Teaching Video Neuro Images : Palatal tremor in adult-onset Alexander disease
Sebesto, Jason R., Gerpen, Jay A. van, Van Gerpen, Jay A

Mayo Clinic

Neurology | June 13, 2016 | Volume: 86 | Issue: 24 | Pages: No page available

10.1212/wnl.0000000000002763 | PMID 27298457 Get It

Survey on the Current State of Endotracheal Intubation Among the Critically Ill
Seisa, Mohamed O. , Gondhi, Venkatesh, Demirci, Onur , Diedrich, Daniel A. , Smischney, Nathan J. , Kashyap, Rahul

Mayo Clinic

Journal of Intensive Care Medicine | June 13, 2016 | Volume: 33 | Issue: 6 | Pages: 354-360

10.1177/0885066616654452 | PMID 27298389 Get It

Objectives: In the last decade, the practice of intubation in the intensive care unit (ICU) has evolved. To further examine the current intubation practice in the ICU, we administered a survey to critical care physicians. Design: Cross-sectional survey study design. Setting: Thirty-two academic/nonacademic centers nationally and internationally. Measurements and Main Results: The survey was developed among a core group of physicians with the assistance of the Survey Research Center at Mayo Clinic, Rochester, Minnesota. The survey was pilot tested for functionality and reliability. The response rate was 82 (51%) of 160 among the 32 centers. Although propofol was the induction drug of choice, there was a significant difference with actual ketamine use and those who indicated a preference for it (ketamine: 52% vs 61%; P < .001). The most common airway device used for intubation was direct laryngoscopy (Miller laryngoscope blade) at 56 (68%) followed by video laryngoscopy at 26 (32%). Most (>90%) indicated that they have a difficult airway cart, but only 55 (67%) indicated they have a documented plan to handle a difficult airway with even lower results for documented review of adverse events (49%). Conclusion: Although propofol was the induction drug of choice, ketamine was a medication that many preferred to use, possibly relating to the fact that the most common complication postintubation is hypotension. Direct laryngoscopy remains the primary airway device for endotracheal intubation. Finally, although the majority stated they had a difficult airway cart available, most did not have a documented plan in place when encountering a difficult airway or a documented process to review adverse events surrounding intubation.
Comparing magnetic resonance angiography (MRA) and computed tomography angiography (CTA) with conventional angiography in the detection of distal territory cerebral mycotic and oncotic aneurysms
Walkoff, Lara , Brinjikji, Waleed , Rouchaud, Aymeric , Caroff, Jildaz , Kallmes, David F. , Rouchaud, Aymeric

Mayo Clinic

Interventional Neuroradiology | June 13, 2016 | Volume: 22 | Issue: 5 | Pages: 524-528

10.1177/1591019916653247 | PMID 27298009 Get It

Background Mycotic and oncotic aneurysms may result in devastating neurologic sequelae if undetected. The objectives of this study were to examine interobserver variability and accuracy of cross-sectional imaging for the detection of distal territory mycotic and oncotic aneurysms. Methods We searched our institutional database for all radiology reports from 2005 to 2015 with an indication or diagnosis of mycotic or oncotic aneurysm. Patients who underwent DSA and either CTA or MRA within 12 weeks of each other were identified. The cross-sectional images from each study were blinded and reviewed by two radiologists. If positive for aneurysm, location and number of aneurysms were reported. Sensitivity, specificity, positive predictive value, negative predictive value, and interobserver variability were determined for MRA and MRA/CTA. Results Twenty-five patients were included in this study. Ten (40%) harbored distal aneurysms. Cross-sectional imaging had a sensitivity of 45.5%, specificity of 90.0%, and kappa value of 0.29 (0.00–0.69) for the detection of cerebral mycotic and oncotic aneurysms. Conclusions Because of the low sensitivity and high interobserver variability of cross-sectional imaging, DSA should remain the gold standard for evaluation of suspected oncotic and mycotic aneurysms. In cases in which cross sectional imaging is negative and there is a high clinical suspicion for mycotic aneurysm, DSA should be strongly considered.
Affinity Selection of FGF2-Binding Heparan Sulfates for Ex Vivo Expansion of Human Mesenchymal Stem Cells
Wijesinghe, Sampath Jeewantha , Murali, Sadasivam, Qing, Yeong Hui, Hinkley, Simon F.R. , Carnachan, Susan , Bell, Tracey , Swaminathan, Kunchithapadam , Hui, James Hoi Po , Wijnen, André J. van , Nurcombe, Victor , Cool, Simon M. , van Wijnen, Andre J, Ling, Ling , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | June 13, 2016 | Volume: 232 | Issue: 3 | Pages: 566-575

10.1002/jcp.25454 | PMID 27291835 Get It

Extended duration strategies for the pharmacologic treatment of diabetic retinopathy: current status and future prospects
Stewart, Michael W., Scott, Ingrid U. , Flynn, Harry W. , Schwartz, Stephen G.

Mayo Clinic

Expert Opinion on Drug Delivery | June 13, 2016 | Volume: 13 | Issue: 9 | Pages: 1277-1287

10.1080/17425247.2016.1198771 | PMID 27293138 Get It